Gonorrhoea is at risk of becoming an untreatable disease due to the continuing emergence of antimicrobial resistance

Since 2011, the approach in the UK and in other countries has been to recommend the use of dual therapy of injectable ceftriaxone and oral azithromycin. Gonorrhoea has rapidly acquired resistance to new antibiotics, leaving few alternatives to the current recommendations. It is therefore extremely important that suboptimal treatment does not occur and, if services lack facilities to provide injectable drugs, patients are referred to a Genitourinary Medicine (GUM) clinic or sexual health service for management

BASSH UK National Guidance for the treatment of Gonorrhoea in Adults 2011

Have a question or query?

Get in touch